129611-31-0

Basic information

• Product Name: 2,4-Dibromo-3-hydroxypyridine
• Synonyms: 2,4-Dibromo-3-hydroxypyridine;2,4-dibromo-3-Pyridinol;2,4-dibromopyridin-3-ol(WXC08100)
• CAS NO: 129611-31-0
• Molecular Formula: C₅H₃Br₂NO
• Molecular Weight: 252.9
• Product Categories: alcohol| alkyl bromide
• Mol File: 129611-31-0.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 322.5±37.0 °C(Predicted)
• Appearance: /
• Density: 2.228±0.06 g/cm3(Predicted)
• PKA: 1.75±0.10(Predicted)
• CAS DataBase Reference: 2,4-Dibromo-3-hydroxypyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 2,4-Dibromo-3-hydroxypyridine(129611-31-0)
• EPA Substance Registry System: 2,4-Dibromo-3-hydroxypyridine(129611-31-0)

Safety Data

• Hazardous Substances Data: 129611-31-0(Hazardous Substances Data)

Usage

General Description

2,4-Dibromo-3-hydroxypyridine is a chemical compound with the molecular formula C5H3Br2NO. It is a derivative of pyridine and contains two bromine atoms and a hydroxyl group attached to the pyridine ring. 2,4-Dibromo-3-hydroxypyridine is used in the pharmaceutical and chemical industries as a building block for the synthesis of various organic compounds. It has been studied for its potential biological activity, including its use as a precursor for the synthesis of potential pharmaceuticals and agrochemicals. Additionally, 2,4-Dibromo-3-hydroxypyridine has been investigated for its potential medicinal properties and its role in the development of new drugs.

Upstream product

• 109-00-2 3-HYDROXYPYRIDINE 

Relevant articles and documents

Chemistry of 3-hydroxypyridine part 1: Bromination and iodination of 3-hydroxypyridine

-

BIPYRIDYL AMINES AND ETHERS AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5

The present invention is directed to novel bipyridyl amine and ether compounds such as those of Formula (I): (I) (where R?1#191, R?2#191, R?3#191, X and Y are as defined herein) which are mGluR5 modulators useful in the treatment or prevention of diseases and conditions in which mGluR5 is involved, including but not limited to psychiatric and mood disorders such as schizophrenia, anxiety, depression, bipolar disorders, and panic, as well as in the treatment of pain, Parkinson’s disease, cognitive dysfunction, epilepsy, circadian rhythm and sleep disorders, such as shift-work induced sleep disorder and jet-lag, drug addiction, drug abuse, drug withdrawal, obesity and other diseases. The invention is also directed to pharmaceutical compositions comprising these compounds. This invention further provides a method of treatment of these disorders and conditions by the administration of an effective amount of these novel bipyridyl amine and/or ether compounds and/or compositions containing these compounds.